Dow Surges 600 Points SP 500 and Nasdaq Rally as Oil Declines and Bond Yields Retreat Ahead of Nvidia Earnings Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement SpaceX Files S1 for IPO Key Takeaways and How AGIX May Offer Exposure Kevin Warsh Set to Assume Federal Reserve Chairmanship in White House Ceremony Fed Rate Hike Expectations Surge Futures Market Prices in Increase as Early as December Stock Futures and Bond Yields Fall on Reports of Putins Updated Nuclear Doctrine Keysight Technologies Q1 2026 Earnings EPS Surges Past Estimates Stock Gains BiomX Inc PHGE Q4 2025 Earnings EPS Misses by Wide Margin No Revenue Stock Declines Eversource Energy ES Q1 2026 Earnings EPS Misses Estimates Stock Inches Higher Box Q1 2026 Earnings Strong EPS Beat Drives Positive Momentum MCW Q1 2026 Earnings EPS Surpasses Estimates with 144 Beat MSA Q1 2026 Earnings EPS Beat Leads to Modest Share Price Gain Dune Acquisition Corporation II IPOD Edges Higher While Holding Above Key Support Amplitech Group Inc Series A Right AMPGR Surges 975 Key Levels to Watch Meshflow Warrants MESHW Hold Steady at 030 as Trading Activity Remains Subdued Rain Enhancement Technologies RAIN Climbs 649 on Renewed Trading Interest Simply Good Foods SMPL Slips 39 as Support Zone Approaches Prediction Market Investments Surge as Companies Stay the Course Despite Regulatory Uncertainty SPGI Q1 2026 Earnings Earnings Beat Estimates Despite Modest Stock Reaction XPeng XPEV Edges Lower Amid Mixed Trading Conditions SELLAS Life Sciences Group SLS Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Focuses on Pipeline Progress Ainos Inc AIMD Q1 2025 Earnings Breakthrough Pipeline Progress Drives Massive Stock Surge Despite No Revenue DIN Q1 2026 Earnings Earnings Beat Amid Mixed Restaurant Performance ELTK Q1 2026 Earnings Negative EPS Amid Quiet Quarter Stock Rises 608 OFG Bancorp OFG Q1 2026 Earnings Strong EPS Beat Offsets Revenue Uncertainty GAIA Q1 2026 Earnings Loss Narrowly Misses Estimates Shares Rise on Strategic Progress Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress